Insights management is never really “finished.” Here’s how medical affairs teams are positioning themselves for continuous improvement.
KOLs outside the traditional physician profile can offer critical insight throughout drug development and launch. Here’s how to include this group in your next ad board.
Forging ahead without needed insights wastes time, money, and opportunity. How can pharma teams close the insight gap?
In our latest episode, an expert explains why pharma teams must include allied health professionals in their key engagements.
The latest news from our product team includes a dramatic rethinking of how insights are collected and shared.
By unlocking real-time, unscripted insights, pharma teams can accelerate strategy. But first, make a plan for assessment and continuous improvement.